Novo Valuation Surpasses Tesla on Experimental Obesity Drug Data
COPENHAGEN, March 7 (Reuters) - Novo Nordisk on Thursday surpassed Tesla Inc in market valuation after the maker of the popular weight-loss drug Wegovy announced positive early trial data for a highly